MENU
+Compare
SOPH
Stock ticker: NASDAQ
AS OF
Sep 2, 04:59 PM (EDT)
Price
$3.42
Change
-$0.04 (-1.16%)
Capitalization
226.39M

SOPH SOPHiA GENETICS SA Forecast, Technical & Fundamental Analysis

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research... Show more

SOPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SOPH with price predictions
Aug 29, 2025

SOPH's Indicator enters downward trend

The Aroon Indicator for SOPH entered a downward trend on August 14, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 160 similar instances where the Aroon Indicator formed such a pattern. In of the 160 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 44 cases where SOPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SOPH as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SOPH broke above its upper Bollinger Band on August 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SOPH just turned positive on August 29, 2025. Looking at past instances where SOPH's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

SOPH moved above its 50-day moving average on August 29, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SOPH crossed bullishly above the 50-day moving average on August 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for SOPH moved above the 200-day moving average on August 22, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SOPH advanced for three days, in of 190 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.952) is normal, around the industry mean (12.220). P/E Ratio (0.000) is within average values for comparable stocks, (82.374). SOPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.777). SOPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.028). P/S Ratio (3.211) is also within normal values, averaging (107.118).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SOPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SOPH is expected to report earnings to fall 39.39% to -20 cents per share on November 11

SOPHiA GENETICS SA SOPH Stock Earnings Reports
Q3'25
Est.
$-0.20
Q2'25
Missed
by $0.11
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.06
The last earnings report on August 05 showed earnings per share of -33 cents, missing the estimate of -21 cents. With 46.47K shares outstanding, the current market capitalization sits at 226.39M.
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
La Pièce 12
Phone
+41 216941060
Employees
449
Web
https://www.sophiagenetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIANY0.06N/A
+1.41%
LianBio
IGGHY14.80N/A
N/A
IG Group Holdings Plc.
SOBS29.10N/A
N/A
Solvay Bank (NY)
AUHYF1.42N/A
N/A
Anadolu Hayat Sigort As
HENKY19.24-0.12
-0.59%
Henkel AG & Co. KGAA

SOPH and Stocks

Correlation & Price change

A.I.dvisor tells us that SOPH and GMGI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SOPH and GMGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
+4.53%
GMGI - SOPH
29%
Poorly correlated
-1.60%
SDGR - SOPH
25%
Poorly correlated
-1.27%
MANH - SOPH
24%
Poorly correlated
-1.38%
PGNY - SOPH
24%
Poorly correlated
+1.81%
PSFE - SOPH
24%
Poorly correlated
N/A
More

Groups containing SOPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOPH
1D Price
Change %
SOPH100%
+4.53%
Health Services
category (436 stocks)
20%
Poorly correlated
+1.00%
Services to the Health Industry
category (93 stocks)
13%
Poorly correlated
+6.59%